Delivery Order SPE2DE21D0007-SPE2D625F1R4B

Award Date 4/7/25
Potential Completion Date 4/10/25
Potential Value $1.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,832.54 delivery order awarded by the Medical Supply Chain, a division of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the supply of "ANTI-A BIOCLONE 15X10ML", a medical diagnostic product, with a period of performance through May 2025. The contract has a fixed price with economic price adjustment pricing type and does not utilize any set-aside designations. Ortho-Clinical Diagnostics, Inc. is a...
This federal contract award, valued at $1,832.54, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the delivery of 4567190755 ANTI-B BIOCLONE 15X10ML, a critical medical diagnostic product. It is a fixed price delivery order with economic price adjustment, with a completion date of February 12, 2025. No set-aside designation was used, indicating open competition....
This federal contract award, valued at $1,832.54, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer registered in SAM.gov. The contract is for the delivery of 4567683435 ! ANTI-B BIOCLONE 15X10ML products, with a completion date of March 27, 2025. This appears to be a delivery order contract with a fixed price with economic price adjustment pricing type. The contract does not utilize any...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the delivery of anti-A bioclone 15x10ml. The contract was awarded by the Medical Supply Chain, a component of the Defense agency, and has a ceiling value of $1,832.54. The contract is a Delivery Order with a fixed price and economic price adjustment pricing type, and has an ultimate completion date of April 28, 2025. The contract does not have a set-aside designation, indicating...
This federal contract award (SPE2DE21D0007|SPE2D625F7R49) was issued by the Medical Supply Chain organization within the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture located in Raritan, New Jersey. The $1,994.20 fixed-price with economic price adjustment delivery order is for the supply of "ANTI-JKA BIOCLONE 1X3ML" medical products, with a performance period ending on March 25, 2025. The...
This federal contract award, valued at $2,072.88, was issued by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc. for the delivery of ANTI-A BIOCLONE 15X10ML medical supplies. The contract was awarded as a fixed price with economic price adjustment delivery order, without any set-aside designation. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including reagents, test kits, and clinical...
This federal contract award, valued at $1,832.54, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The contract is for the delivery of ANTI-A BIOCLONE 15X10ML, a medical product. The contract does not have a set-aside designation and was awarded on a competitive basis. Ortho-Clinical Diagnostics, Inc. has previously provided various medical equipment, reagents, consumables, and...
This federal contract award, with ID SPE2DE21D0007|SPE2D624F5M1P, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,746.00 fixed-price with economic price adjustment delivery order is for the supply of 4564636234 ! ANTI-A BIOCLONE 15X10ML products. The contract has a completion date of May 20, 2024. Ortho-Clinical Diagnostics holds several...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, to provide anti-A bioclone 15x10mL to a U.S. government agency. The contract has a ceiling value of $1,497.37 and is a delivery order with a fixed price and economic price adjustment. The ultimate completion date is February 28, 2025, and the award date is February 25, 2025. The contract does not have a set-aside designation, indicating open competition. The awarding agency is the...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense Department's Defense Health Agency. The $1,767.32 firm fixed-price delivery order is for the supply of 4,568,212,039 units of Anti-A,B Bioclone 15x10ml. The contract has a June 2, 2025 completion date and does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified...
  • SPE2DE21D0007
    Indefinite Delivery Contract
  • SPE2DE21D0007-SPE2D625F1R4B
    Delivery Order

This federal contract award, identified as SPE2DE21D0007|SPE2D625F1R4B, was issued by the Medical Supply Chain, a component of the Defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,832.54 fixed-price contract with economic price adjustment is for the delivery of "ANTI-A BIOCLONE 15X10ML" medical supplies. This appears to be a delivery order under a larger contract vehicle, as the award notice references Ortho-Clinical Diagnostics' existing Indefinite Delivery Contracts and Blanket Purchase Agreements with various Veterans Integrated Service Networks and other federal agencies for medical diagnostic equipment, reagents, and related services. The contract does not have a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and manufacturer of goods, with a primary place of performance in Raritan, New Jersey.

Generated 7/7/25, 1:10 PM